Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression
Capitolo di libro
Data di Pubblicazione:
2008
Citazione:
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression / Festi, Davide; Lodato, Francesca; Mazzella, Giuseppe; Colecchia, Antonio. - (2008), pp. 215-236. [10.1007/978-0-387-71376-2_11]
Abstract:
Chronic HCV hepatitis is a progressive disease; if not treated it progress towards liver cirrhosis, hepatocellular carcinoma and/or liver insufficiency. Different antiviral treatments are now available, whose success rate ranging from 20 to 65% of the patients, depending on factors related to the virus (viral load, genotype, etc) or to the host (gender, age, time of infections, precence of comorbidities).
Tipologia CRIS:
Capitolo/Saggio
Keywords:
CHRONIC VIRAL HEPATITIS; ANTIVIRAL HEPATITIS; HEPATOCELLULAR CARCINOMA; LIVER CIRRHOSIS
Elenco autori:
Festi, Davide; Lodato, Francesca; Mazzella, Giuseppe; Colecchia, Antonio
Link alla scheda completa:
Titolo del libro:
Hepatitis C Virus Disease. Immunobiology and Clinical Applications